Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.25p
   
  • Change Today:
      0.001p
  • 52 Week High: 2.05p
  • 52 Week Low: 1.10p
  • Currency: UK Pounds
  • Shares Issued: 979.75m
  • Volume: 1,137,104
  • Market Cap: £12.29m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 75,090,685 £941,637
Vladislav Sandler Ph.D. 41,544,677 £520,970
Peter Redmond 5,596,270 £70,177

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 75,090,685 £941,637
Dr Vladislav Sandler 41,544,677 £520,970
Optiva Securities Limited 28,131,723 £352,772
Flascherberg Capital Anstalt 27,996,487 £351,076
Craig Auringer 23,837,250 £298,919
HSBC Client Holdings Nominee (UK) Limited 18,063,805 £226,520
Ron Valk 17,131,193 £214,825
Samantha Bauer 17,082,201 £214,211
Plum Capital 11,692,863 £146,628
43 North LLC 11,371,429 £142,598
Abdelatif LACHAB 2,600,000 £32,604
Wayne Gibson 2,600,000 £32,604

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.25p
Change Today 0.001p
% Change -0.08 %
52 Week High 2.05p
52 Week Low 1.10p
Volume 1,137,104
Shares Issued 979.75m
Market Cap £12.29m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.28% above the market average3.28% above the market average3.28% above the market average3.28% above the market average3.28% above the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Price Trend
62.43% below the market average62.43% below the market average62.43% below the market average62.43% below the market average62.43% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 01-Dec-2022

Time Volume / Share Price
11:43 976 @ 1.25p
11:33 13,738 @ 1.25p
11:02 23,823 @ 1.25p
10:33 5,000 @ 1.25p
10:29 120,000 @ 1.25p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page